Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease

Background & Aims Multiparametric magnetic resonance (MR) imaging has been demonstrated to quantify hepatic fibrosis, iron, and steatosis. The aim of this study was to determine if MR can be used to predict negative clinical outcomes in liver disease patients. Methods Patients with chronic l...

Cijeli opis

Bibliografski detalji
Glavni autori: Pavlides, M, Banerjee, R, Sellwood, J, Kelly, C, Robson, M, Booth, J, Collier, J, Neubauer, S, Barnes, E
Format: Journal article
Jezik:English
Izdano: Elsevier 2015
_version_ 1826289184039501824
author Pavlides, M
Banerjee, R
Sellwood, J
Kelly, C
Robson, M
Booth, J
Collier, J
Neubauer, S
Barnes, E
author_facet Pavlides, M
Banerjee, R
Sellwood, J
Kelly, C
Robson, M
Booth, J
Collier, J
Neubauer, S
Barnes, E
author_sort Pavlides, M
collection OXFORD
description Background & Aims Multiparametric magnetic resonance (MR) imaging has been demonstrated to quantify hepatic fibrosis, iron, and steatosis. The aim of this study was to determine if MR can be used to predict negative clinical outcomes in liver disease patients. Methods Patients with chronic liver disease (n = 112) were recruited for MR imaging and data on the development of liver related clinical events were collected by medical records review. The median follow-up was 27 months. MR data were analysed blinded for the Liver Inflammation and Fibrosis score (LIF; <1, 1–1.99, 2–2.99, and ⩾3 representing normal, mild, moderate, and severe liver disease, respectively), T2∗ for liver iron content and proportion of liver fat. Baseline liver biopsy was performed in 102 patients. Results Liver disease aetiologies included non-alcoholic fatty liver disease (35%) and chronic viral hepatitis (30%). Histologically, fibrosis was mild in 54 (48%), moderate in 17 (15%), and severe in 31 (28%) patients. Overall mortality was 5%. Ten patients (11%) developed at least one liver related clinical event. The negative predictive value of LIF <2 was 100%. Two patients with LIF 2–2.99 and eight with LIF ⩾3 had a clinical event. Patients with LIF ⩾3 had a higher cumulative risk for developing clinical events, compared to those with LIF <1 (p = 0.02) and LIF 1–1.99 (p = 0.03). Cox regression analysis including all 3 variables (fat, iron, LIF) resulted in an enhanced LIF predictive value. Conclusions Non-invasive standardised multiparametric MR technology may be used to predict clinical outcomes in patients with chronic liver disease.
first_indexed 2024-03-07T02:25:01Z
format Journal article
id oxford-uuid:a54c1cad-1db0-412c-b1d9-42c518d9e5ad
institution University of Oxford
language English
last_indexed 2024-03-07T02:25:01Z
publishDate 2015
publisher Elsevier
record_format dspace
spelling oxford-uuid:a54c1cad-1db0-412c-b1d9-42c518d9e5ad2022-03-27T02:39:31ZMultiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver diseaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a54c1cad-1db0-412c-b1d9-42c518d9e5adEnglishSymplectic Elements at OxfordElsevier2015Pavlides, MBanerjee, RSellwood, JKelly, CRobson, MBooth, JCollier, JNeubauer, SBarnes, EBackground & Aims Multiparametric magnetic resonance (MR) imaging has been demonstrated to quantify hepatic fibrosis, iron, and steatosis. The aim of this study was to determine if MR can be used to predict negative clinical outcomes in liver disease patients. Methods Patients with chronic liver disease (n = 112) were recruited for MR imaging and data on the development of liver related clinical events were collected by medical records review. The median follow-up was 27 months. MR data were analysed blinded for the Liver Inflammation and Fibrosis score (LIF; <1, 1–1.99, 2–2.99, and ⩾3 representing normal, mild, moderate, and severe liver disease, respectively), T2∗ for liver iron content and proportion of liver fat. Baseline liver biopsy was performed in 102 patients. Results Liver disease aetiologies included non-alcoholic fatty liver disease (35%) and chronic viral hepatitis (30%). Histologically, fibrosis was mild in 54 (48%), moderate in 17 (15%), and severe in 31 (28%) patients. Overall mortality was 5%. Ten patients (11%) developed at least one liver related clinical event. The negative predictive value of LIF <2 was 100%. Two patients with LIF 2–2.99 and eight with LIF ⩾3 had a clinical event. Patients with LIF ⩾3 had a higher cumulative risk for developing clinical events, compared to those with LIF <1 (p = 0.02) and LIF 1–1.99 (p = 0.03). Cox regression analysis including all 3 variables (fat, iron, LIF) resulted in an enhanced LIF predictive value. Conclusions Non-invasive standardised multiparametric MR technology may be used to predict clinical outcomes in patients with chronic liver disease.
spellingShingle Pavlides, M
Banerjee, R
Sellwood, J
Kelly, C
Robson, M
Booth, J
Collier, J
Neubauer, S
Barnes, E
Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
title Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
title_full Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
title_fullStr Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
title_full_unstemmed Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
title_short Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
title_sort multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
work_keys_str_mv AT pavlidesm multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease
AT banerjeer multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease
AT sellwoodj multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease
AT kellyc multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease
AT robsonm multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease
AT boothj multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease
AT collierj multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease
AT neubauers multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease
AT barnese multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease